AR004703A1 - HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES. - Google Patents
HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES.Info
- Publication number
- AR004703A1 AR004703A1 ARP960104972A ARP960104972A AR004703A1 AR 004703 A1 AR004703 A1 AR 004703A1 AR P960104972 A ARP960104972 A AR P960104972A AR P960104972 A ARP960104972 A AR P960104972A AR 004703 A1 AR004703 A1 AR 004703A1
- Authority
- AR
- Argentina
- Prior art keywords
- bis
- preparation
- hydrazidil
- hydrazil
- aminometil
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos de fórmula (I) que inhiben proteasas, con inclusión de catepsina K, composiciones farmacéuticas que dichos compuestos y uso de dichos compuestosen la preparación de medicamentos para el tratamiento de enfermedades de pérdida ósea odegradación de cartílago o matriz excesivas, con inclusión deosteoporosis; enfermedad gingival con inclusión de gingivitis y periodontitis; artritis, más específicamente, osteoartritis y artritis reumatoide; enfermedadde Paget, hipercalcemia decará cter maligno; y enfermedad metabólica ósea, donde la definición de los sustituyentes son tal como figuran en la memoria.Compounds of formula (I) that inhibit proteases, including cathepsin K, pharmaceutical compositions thereof, and use of said compounds in the preparation of medicaments for the treatment of diseases of excessive bone loss or cartilage or matrix degradation, including deosteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease, hypercalcemia of malignant character; and metabolic bone disease, where the definition of the substituents are as stated in the specification.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US810895P | 1995-10-30 | 1995-10-30 | |
| US747395P | 1995-11-22 | 1995-11-22 | |
| US899295P | 1995-12-21 | 1995-12-21 | |
| US1374896P | 1996-03-20 | 1996-03-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR004703A1 true AR004703A1 (en) | 1999-03-10 |
Family
ID=27485695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP960104972A AR004703A1 (en) | 1995-10-30 | 1996-10-30 | HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES. |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR004703A1 (en) |
| BR (1) | BR9612344A (en) |
-
1996
- 1996-10-30 BR BR9612344A patent/BR9612344A/en not_active Application Discontinuation
- 1996-10-30 AR ARP960104972A patent/AR004703A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9612344A (en) | 1999-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE411294T1 (en) | 4-AMINO-AZEPAN-3-ON DERIVATIVES AS PROTEASE INHIBITORS | |
| AP9801222A0 (en) | Proatease inhibitors. | |
| AR012172A2 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING ANALOGS OF LACTACISTIN AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| BR9611175B1 (en) | pharmaceutical compounds and compositions. | |
| MY141596A (en) | Protease inhibitors | |
| ES2136037B1 (en) | SULFAMIDE-METALOPROTEASE INHIBITORS | |
| TR199902703T2 (en) | Protease inhibitors. | |
| UY27700A1 (en) | OXO COMPOUNDS - AZABYCLES. | |
| ES2175155T3 (en) | AROMATIC CETOACIDOS AND ITS DERIVATIVES AS INHIBITORS OF MATRAL METALOPROTEINASES. | |
| ES2116612T3 (en) | NEW BIS-NAFTALIMIDES FOR THE TREATMENT OF CANCER. | |
| AP2002002671A0 (en) | Protease inhibitors. | |
| ES2173195T3 (en) | ANTHRACICLINE DERIVATIVES. | |
| HK1042695A1 (en) | Prothease inhibitors | |
| UY26088A1 (en) | PROTEASE INHIBITORS | |
| HK1041690A1 (en) | Protease inhibitors | |
| AR004703A1 (en) | HYDRAZIDIL, BIS-HYDRAZIL AND BIS-AMINOMETIL-CARBONIL, PROTEASE INHIBITORS, A PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING PROTEASES, AND USE IN THE PREPARATION OF MEDICINES. | |
| UY26026A1 (en) | PROTEASE INHIBITORS | |
| WO2002092563A3 (en) | Protease inhibitors | |
| UY27032A1 (en) | PROTEASE INHIBITORS | |
| ECSP003403A (en) | PROTEASE INHIBITORS XI | |
| ECSP982493A (en) | PROTEASE INHIBITORS III | |
| AR023344A1 (en) | 4-ARYLOXYINDOLES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES | |
| ECSP982486A (en) | PROTEASE INHIBITORS II | |
| NZ324101A (en) | Protease inhibitors, pharmaceutical compositions and use thereof | |
| UY24550A1 (en) | PROTEASE INHIBITORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal | ||
| FB | Suspension of granting procedure |